Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Pancreatic Neoplasms: HELP
Elena Gabriela Chiorean
Based on 28 articles published since 2008
||||
Expertise Level
The expertise of Elena Gabriela Chiorean ranks in the
  • Top 0.13%
  • ... of 94,906 published authors worldwide on Pancreatic Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 28 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Chiorean, E Gabriela   ·   Chiorean, Elena G   ·   Chiorean, Elena Gabriela   ·   Chiorean, E G
Work Locations
Details
Most likely:    University of Washington   Contact    
2018
  • Division of Medical Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. · Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Division of Medical Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Pubmed 30391013
  • Department of Environmental Health, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Pubmed 29474406
  • Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Indiana University Cancer Center, Indianapolis, IN, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Gabrail Cancer Center, Canton, OH, USA. · McGill University Health Centre, Montreal, QC, Canada. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Duke University Medical Center, Durham, NC, USA. · Pubmed 29238851
2016
  • From the Division of Hematology-Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD; University of Michigan, Ann Arbor, MI. · Pubmed 27249726
  • Department of Medicine/Division Oncology, University of Washington, Fred Hutchinson Cancer Research Center, 825 Eastlake Ave E, G4-833, Seattle, WA 98109-1023, USA. · NewLink Genetics, Ames, IA 50010, USA. · Pubmed 26787078
  • a University of Washington , Seattle , WA , USA. · b NewLink Genetics , Ames , IA , USA. · Pubmed 26619245
  • Division Oncology, Department of Medicine, University of Washington, 825 Eastlake Avenue E, G4-833, Seattle, WA 98109-1023, USA. · Translational Genomics Research Institute and HonorHealth, 445 North Fifth Street, Suite 600, Phoenix, AZ 85004, USA. · Vall d'Hebron Institute of Oncology (VHIO), P Vall d'Hebron 119-129, Barcelona 08035, Spain. · Royal Victoria Hospital Barrie Canada, 201 Georgian Drive, Barrie, Ontario, Canada L4M 6M2. · Roswell Park Cancer Institute, 665 Elm Street, Buffalo, NY 14203, USA. · San Raffaele Scientific Institute, Via Olgetina 60, 20132 Milan, Italy. · Monash Health, 246 Clayton Road, Melbourne VIC 3168, Australia. · Florida Cancer Specialists, 2401 60th Street Ct W, Bradenton, FL 34209-5500, USA. · Celgene Corporation, 86 Morris Avenue, Summit, NJ 07901, USA. · Department of Medical Oncology, Prince of Wales Hospital, South Sydney Illawarra, Barker Street, Sydney NSW 2031, Australia. · Pubmed 27351217
  • Department of Medicine/Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle · HonorHealth and The Translational Genomics Research Institute (TGen), Scottsdale, USA. · Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy. · Department of Oncology, NYU Langone Arena Oncology, Lake Success. · Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville. · Cancer Center of Excellence, University of Massachusetts Medical School, Worcester. · UAB Comprehensive Cancer Center, Birmingham, USA. · Mater Private Centre for Haematology & Oncology, South Brisbane, Australia. · Department of Oncology, Genesis Cancer Center, Hot Springs, USA. · Southern Medical Day Care Centre, Wollongong, Australia. · Medizinische Klinik und Poliklinik II, University of Wuerzburg, Wuerzburg, Germany. · Medical of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Oncology, Prince of Wales Hospital, Sydney, Australia. · Celgene Corporation, Summit, USA. · Pubmed 26802160
  • Departments of Hematology/Oncology, Mayo Clinic, Phoenix. · Core Lab, Imaging Endpoints, Scottsdale. · Division of Medical Oncology, University of Washington, Seattle, WA. · Department of Biostatistics, Celgene Corporation, Summit, NJ. · Translational Drug Development, Translational Genomics Research Institute and Honor Health, Phoenix, USA · Pubmed 27240995
2015
  • Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA. · Pubmed 26185420
2014
  • aDepartment of Medicine, University of Washington, Seattle, Washington bTranslational Genomics Research Institute (TGen)/Virginia Piper Cancer Center, Scottsdale, Arizona, USA. · Pubmed 24463484
  • Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana; Department of Medicine, University of Washington, Seattle, Washington. Electronic address: · Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiology, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana. · Pubmed 24726286
  • Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America; University of Washington, Seattle, Washington, United States of America. · Pubmed 24651674
2013
  • From the Translational Genomics Research Institute, Phoenix, and Virginia G. Piper Cancer Center, Scottsdale - both in Arizona (D.D.V.H., R.K.R.) · Cancer Specialists, Fort Myers, FL (T.E.) · Arena Oncology Associates, Lake Success (F.P.A.), and Roswell Park Cancer Institute, Buffalo (W.W.M.) - both in New York · University of Washington, Seattle (E.G.C.) · Sarah Cannon Research Institute-Tennessee Oncology, Nashville (J. Infante) · Princess Margaret Hospital, Toronto (M.M.) · Atlanta Cancer Care (T.S.) and Georgia Cancer Specialists (M.N.S.) - both in Atlanta · Blokhin Cancer Research Center, Moscow (S.A.T.) · Southern Health, East Bentleigh, VIC (M.H.), Prince of Wales Hospital, Sydney (D.G.), and Bionomics, Thebarton, SA (J. Iglesias) - all in Australia · San Raffaele Scientific Institute, Milan (M.R.) · Tom Baker Cancer Centre, Calgary, AB, Canada (S.D.) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (D.L.) · University of Pittsburgh Medical Center, Pittsburgh (N.B.) · Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona (J.T.) · Centro Integral Oncológico Clara Campal, Madrid (M.H.) · University Hospitals Leuven and Katholieke Universiteit Leuven, Leuven, Belgium (E.V.C.) · and Celgene, Summit, NJ (X.W., M.F.R.). · Pubmed 24131140
  • Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA. · Division of Hematology-Oncology, Department of Medicine. · Department of Radiology. · University of Washington, Seattle, WA. · Department of Biostatistics and Epidemiology. · University of Pittsburgh Cancer Institute, Pittsburgh, PA. · Abramson Family Cancer Research Institute. · Pubmed 23983255
2017
  • *Division of Hematology/Oncology Departments of †Biostatistics ‡Surgery §Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN ∥Department of Medicine, Division of Hematology/Oncology, University of Washington, Seattle, WA. · Pubmed 25121637
2015
  • Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Oncology, University of Washington, Seattle, Washington, USA; Department of Oncology/Hematology, Sarah Cannon Research Institute, Nashville, Tennessee, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Oncology, Peninsula Oncology Centre, Monash University, Frankston, Victoria, Australia; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA; Division of Clinical Oncology, Medizinische Universität Wien, Vienna, Austria; Mayo Clinic, Scottsdale, Arizona, USA; Department of Oncology, Prince of Wales Hospital, Randwick, New South Wales, Sydney, Australia; Celgene Corporation, Summit, New Jersey, USA; Department of Oncology, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, Scottsdale, Arizona, USA · Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Oncology, University of Washington, Seattle, Washington, USA; Department of Oncology/Hematology, Sarah Cannon Research Institute, Nashville, Tennessee, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Oncology, Peninsula Oncology Centre, Monash University, Frankston, Victoria, Australia; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA; Division of Clinical Oncology, Medizinische Universität Wien, Vienna, Austria; Mayo Clinic, Scottsdale, Arizona, USA; Department of Oncology, Prince of Wales Hospital, Randwick, New South Wales, Sydney, Australia; Celgene Corporation, Summit, New Jersey, USA; Department of Oncology, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, Scottsdale, Arizona, USA. · Pubmed 25582141
2014
  • From UCSF Helen Diller Family Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; Pancreatic Cancer Action Network (PanCAN); University of Michigan Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Stanford Cancer Institute; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute at the University of Utah; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Massachusetts General Hospital Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network. · Pubmed 25099441
Probable:    Indiana University Indianapolis   Contact    
2018
  • Department of Environmental Health, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Pubmed 29474406
  • Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Indiana University Cancer Center, Indianapolis, IN, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Gabrail Cancer Center, Canton, OH, USA. · McGill University Health Centre, Montreal, QC, Canada. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Duke University Medical Center, Durham, NC, USA. · Pubmed 29238851
2015
  • Mitesh J. Borad, Mayo Clinic, Scottsdale · Tomislav Dragovich, Arizona Cancer Center, Tucson, AZ · Shantan G. Reddy, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA · Nathan Bahary, University of Pittsburgh Medical Center, Pittsburgh, PA · Hope E. Uronis, Duke University Medical Center, Durham, NC · Darren Sigal, Scripps Clinic, La Jolla · Peter J. Rosen, Disney Family Cancer Center, Burbank · Clarence Eng and Stew Kroll, Threshold Pharmaceuticals, South San Francisco, CA · Allen L. Cohn, Rocky Mountain Cancer Center, Denver, CO · William R. Schelman, University of Wisconsin Carbone Cancer Center, Madison, WI · Joe Stephenson Jr, Institute for Translational Oncology Research, Greenville, SC · E. Gabriela Chiorean, Indiana University Simon Cancer Center, Indianapolis, IN · Brian Ulrich, Texas Oncology, Wichita Falls, TX · Salvatore A. Del Prete, Hematology Oncology PC, Stamford, CT · Mark Rarick, Kaiser Permanente Northwest Region Oncology Hematology, Portland, OR · and David P. Ryan, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 25512461
2014
  • Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana; Department of Medicine, University of Washington, Seattle, Washington. Electronic address: · Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiology, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana. · Pubmed 24726286
  • Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America; University of Washington, Seattle, Washington, United States of America. · Pubmed 24651674
2010
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA. · Pubmed 19687729
2017
  • *Division of Hematology/Oncology Departments of †Biostatistics ‡Surgery §Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN ∥Department of Medicine, Division of Hematology/Oncology, University of Washington, Seattle, WA. · Pubmed 25121637
2013
  • Division of Medical Oncology, IU Simon Cancer Center, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Pubmed 23468532
  • Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America. · Pubmed 23451150
2011
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA. · Pubmed 20881474
2010
  • Department of Radiology, Indiana University School of Medicine, 550 N University Blvd, Room 0279, Indianapolis, IN 46202, USA. · Pubmed 20515976
Probable:    University of Michigan   Contact    
2016
  • From the Division of Hematology-Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD; University of Michigan, Ann Arbor, MI. · Pubmed 27249726
2014
  • From UCSF Helen Diller Family Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; Pancreatic Cancer Action Network (PanCAN); University of Michigan Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Stanford Cancer Institute; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute at the University of Utah; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Massachusetts General Hospital Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network. · Pubmed 25099441
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 28 total) written by Elena Gabriela Chiorean about Pancreatic Neoplasms:

  • Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma. 2018
  • The role of the folate pathway in pancreatic cancer risk. 2018
  • Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors. 2018
  • Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
  • Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection: The Indiana University Experience. 2017
  • Localized Pancreatic Cancer: Multidisciplinary Management. 2016
  • Algenpantucel-L immunotherapy in pancreatic adenocarcinoma. 2016
  • Pancreatic cancer: Update on immunotherapies and algenpantucel-L. 2016
  • Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer. 2016
  • CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Elena Gabriela Chiorean using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Washington
Indiana University Indianapolis
University of Michigan
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Washington
2018
  • Division of Medical Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. · Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. Electronic address: · Division of Medical Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: · Pubmed 30391013
  • Department of Environmental Health, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Pubmed 29474406
  • Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Indiana University Cancer Center, Indianapolis, IN, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Gabrail Cancer Center, Canton, OH, USA. · McGill University Health Centre, Montreal, QC, Canada. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Duke University Medical Center, Durham, NC, USA. · Pubmed 29238851
2016
  • From the Division of Hematology-Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD; University of Michigan, Ann Arbor, MI. · Pubmed 27249726
  • Department of Medicine/Division Oncology, University of Washington, Fred Hutchinson Cancer Research Center, 825 Eastlake Ave E, G4-833, Seattle, WA 98109-1023, USA. · NewLink Genetics, Ames, IA 50010, USA. · Pubmed 26787078
  • a University of Washington , Seattle , WA , USA. · b NewLink Genetics , Ames , IA , USA. · Pubmed 26619245
  • Division Oncology, Department of Medicine, University of Washington, 825 Eastlake Avenue E, G4-833, Seattle, WA 98109-1023, USA. · Translational Genomics Research Institute and HonorHealth, 445 North Fifth Street, Suite 600, Phoenix, AZ 85004, USA. · Vall d'Hebron Institute of Oncology (VHIO), P Vall d'Hebron 119-129, Barcelona 08035, Spain. · Royal Victoria Hospital Barrie Canada, 201 Georgian Drive, Barrie, Ontario, Canada L4M 6M2. · Roswell Park Cancer Institute, 665 Elm Street, Buffalo, NY 14203, USA. · San Raffaele Scientific Institute, Via Olgetina 60, 20132 Milan, Italy. · Monash Health, 246 Clayton Road, Melbourne VIC 3168, Australia. · Florida Cancer Specialists, 2401 60th Street Ct W, Bradenton, FL 34209-5500, USA. · Celgene Corporation, 86 Morris Avenue, Summit, NJ 07901, USA. · Department of Medical Oncology, Prince of Wales Hospital, South Sydney Illawarra, Barker Street, Sydney NSW 2031, Australia. · Pubmed 27351217
  • Department of Medicine/Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle · HonorHealth and The Translational Genomics Research Institute (TGen), Scottsdale, USA. · Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy. · Department of Oncology, NYU Langone Arena Oncology, Lake Success. · Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville. · Cancer Center of Excellence, University of Massachusetts Medical School, Worcester. · UAB Comprehensive Cancer Center, Birmingham, USA. · Mater Private Centre for Haematology & Oncology, South Brisbane, Australia. · Department of Oncology, Genesis Cancer Center, Hot Springs, USA. · Southern Medical Day Care Centre, Wollongong, Australia. · Medizinische Klinik und Poliklinik II, University of Wuerzburg, Wuerzburg, Germany. · Medical of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · Department of Oncology, Prince of Wales Hospital, Sydney, Australia. · Celgene Corporation, Summit, USA. · Pubmed 26802160
  • Departments of Hematology/Oncology, Mayo Clinic, Phoenix. · Core Lab, Imaging Endpoints, Scottsdale. · Division of Medical Oncology, University of Washington, Seattle, WA. · Department of Biostatistics, Celgene Corporation, Summit, NJ. · Translational Drug Development, Translational Genomics Research Institute and Honor Health, Phoenix, USA · Pubmed 27240995
2015
  • Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA. · Pubmed 26185420
2014
  • aDepartment of Medicine, University of Washington, Seattle, Washington bTranslational Genomics Research Institute (TGen)/Virginia Piper Cancer Center, Scottsdale, Arizona, USA. · Pubmed 24463484
  • Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana; Department of Medicine, University of Washington, Seattle, Washington. Electronic address: · Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiology, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana. · Pubmed 24726286
  • Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America; University of Washington, Seattle, Washington, United States of America. · Pubmed 24651674
2013
  • From the Translational Genomics Research Institute, Phoenix, and Virginia G. Piper Cancer Center, Scottsdale - both in Arizona (D.D.V.H., R.K.R.) · Cancer Specialists, Fort Myers, FL (T.E.) · Arena Oncology Associates, Lake Success (F.P.A.), and Roswell Park Cancer Institute, Buffalo (W.W.M.) - both in New York · University of Washington, Seattle (E.G.C.) · Sarah Cannon Research Institute-Tennessee Oncology, Nashville (J. Infante) · Princess Margaret Hospital, Toronto (M.M.) · Atlanta Cancer Care (T.S.) and Georgia Cancer Specialists (M.N.S.) - both in Atlanta · Blokhin Cancer Research Center, Moscow (S.A.T.) · Southern Health, East Bentleigh, VIC (M.H.), Prince of Wales Hospital, Sydney (D.G.), and Bionomics, Thebarton, SA (J. Iglesias) - all in Australia · San Raffaele Scientific Institute, Milan (M.R.) · Tom Baker Cancer Centre, Calgary, AB, Canada (S.D.) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (D.L.) · University of Pittsburgh Medical Center, Pittsburgh (N.B.) · Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona (J.T.) · Centro Integral Oncológico Clara Campal, Madrid (M.H.) · University Hospitals Leuven and Katholieke Universiteit Leuven, Leuven, Belgium (E.V.C.) · and Celgene, Summit, NJ (X.W., M.F.R.). · Pubmed 24131140
  • Abramson Cancer Center; University of Pennsylvania, Philadelphia, PA. · Division of Hematology-Oncology, Department of Medicine. · Department of Radiology. · University of Washington, Seattle, WA. · Department of Biostatistics and Epidemiology. · University of Pittsburgh Cancer Institute, Pittsburgh, PA. · Abramson Family Cancer Research Institute. · Pubmed 23983255
2017
  • *Division of Hematology/Oncology Departments of †Biostatistics ‡Surgery §Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN ∥Department of Medicine, Division of Hematology/Oncology, University of Washington, Seattle, WA. · Pubmed 25121637
2015
  • Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Oncology, University of Washington, Seattle, Washington, USA; Department of Oncology/Hematology, Sarah Cannon Research Institute, Nashville, Tennessee, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Oncology, Peninsula Oncology Centre, Monash University, Frankston, Victoria, Australia; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA; Division of Clinical Oncology, Medizinische Universität Wien, Vienna, Austria; Mayo Clinic, Scottsdale, Arizona, USA; Department of Oncology, Prince of Wales Hospital, Randwick, New South Wales, Sydney, Australia; Celgene Corporation, Summit, New Jersey, USA; Department of Oncology, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, Scottsdale, Arizona, USA · Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Oncology, University of Washington, Seattle, Washington, USA; Department of Oncology/Hematology, Sarah Cannon Research Institute, Nashville, Tennessee, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Oncology, Peninsula Oncology Centre, Monash University, Frankston, Victoria, Australia; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA; Division of Clinical Oncology, Medizinische Universität Wien, Vienna, Austria; Mayo Clinic, Scottsdale, Arizona, USA; Department of Oncology, Prince of Wales Hospital, Randwick, New South Wales, Sydney, Australia; Celgene Corporation, Summit, New Jersey, USA; Department of Oncology, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, Scottsdale, Arizona, USA. · Pubmed 25582141
2014
  • From UCSF Helen Diller Family Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; Pancreatic Cancer Action Network (PanCAN); University of Michigan Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Stanford Cancer Institute; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute at the University of Utah; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Massachusetts General Hospital Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network. · Pubmed 25099441
Indiana University Indianapolis
2018
  • Department of Environmental Health, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, Indiana, United States of America. · University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Pubmed 29474406
  • Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. · Indiana University Cancer Center, Indianapolis, IN, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Gabrail Cancer Center, Canton, OH, USA. · McGill University Health Centre, Montreal, QC, Canada. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Mirati Therapeutics Inc., 9393 Towne Centre Drive, Suite 200, San Diego, CA, 92121, USA. · Duke University Medical Center, Durham, NC, USA. · Pubmed 29238851
2015
  • Mitesh J. Borad, Mayo Clinic, Scottsdale · Tomislav Dragovich, Arizona Cancer Center, Tucson, AZ · Shantan G. Reddy, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA · Nathan Bahary, University of Pittsburgh Medical Center, Pittsburgh, PA · Hope E. Uronis, Duke University Medical Center, Durham, NC · Darren Sigal, Scripps Clinic, La Jolla · Peter J. Rosen, Disney Family Cancer Center, Burbank · Clarence Eng and Stew Kroll, Threshold Pharmaceuticals, South San Francisco, CA · Allen L. Cohn, Rocky Mountain Cancer Center, Denver, CO · William R. Schelman, University of Wisconsin Carbone Cancer Center, Madison, WI · Joe Stephenson Jr, Institute for Translational Oncology Research, Greenville, SC · E. Gabriela Chiorean, Indiana University Simon Cancer Center, Indianapolis, IN · Brian Ulrich, Texas Oncology, Wichita Falls, TX · Salvatore A. Del Prete, Hematology Oncology PC, Stamford, CT · Mark Rarick, Kaiser Permanente Northwest Region Oncology Hematology, Portland, OR · and David P. Ryan, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 25512461
2014
  • Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana; Department of Medicine, University of Washington, Seattle, Washington. Electronic address: · Department of Medicine, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiology, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. · Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana. · Pubmed 24726286
  • Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Department of Environmental Health, Indiana University, Bloomington, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University School of Medicine, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America. · Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States of America; University of Washington, Seattle, Washington, United States of America. · Pubmed 24651674
2010
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA. · Pubmed 19687729
2017
  • *Division of Hematology/Oncology Departments of †Biostatistics ‡Surgery §Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN ∥Department of Medicine, Division of Hematology/Oncology, University of Washington, Seattle, WA. · Pubmed 25121637
2013
  • Division of Medical Oncology, IU Simon Cancer Center, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · Pubmed 23468532
  • Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America. · Pubmed 23451150
2011
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA. · Pubmed 20881474
2010
  • Department of Radiology, Indiana University School of Medicine, 550 N University Blvd, Room 0279, Indianapolis, IN 46202, USA. · Pubmed 20515976
University of Michigan
2016
  • From the Division of Hematology-Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD; University of Michigan, Ann Arbor, MI. · Pubmed 27249726
2014
  • From UCSF Helen Diller Family Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; Pancreatic Cancer Action Network (PanCAN); University of Michigan Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Stanford Cancer Institute; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute at the University of Utah; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Massachusetts General Hospital Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network. · Pubmed 25099441
Johns Hopkins University
2016
  • From the Division of Hematology-Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, MD; University of Michigan, Ann Arbor, MI. · Pubmed 27249726
2014
  • From UCSF Helen Diller Family Comprehensive Cancer Center; Moffitt Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; City of Hope Comprehensive Cancer Center; Fox Chase Cancer Center; Duke Cancer Institute; Pancreatic Cancer Action Network (PanCAN); University of Michigan Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Stanford Cancer Institute; UC San Diego Moores Cancer Center; Roswell Park Cancer Institute; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute at the University of Utah; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Massachusetts General Hospital Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; University of Colorado Cancer Center; The University of Texas MD Anderson Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network. · Pubmed 25099441
Translational Genomics Research Institute
2014
  • aDepartment of Medicine, University of Washington, Seattle, Washington bTranslational Genomics Research Institute (TGen)/Virginia Piper Cancer Center, Scottsdale, Arizona, USA. · Pubmed 24463484
2015
  • Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Oncology, University of Washington, Seattle, Washington, USA; Department of Oncology/Hematology, Sarah Cannon Research Institute, Nashville, Tennessee, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Oncology, Peninsula Oncology Centre, Monash University, Frankston, Victoria, Australia; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA; Division of Clinical Oncology, Medizinische Universität Wien, Vienna, Austria; Mayo Clinic, Scottsdale, Arizona, USA; Department of Oncology, Prince of Wales Hospital, Randwick, New South Wales, Sydney, Australia; Celgene Corporation, Summit, New Jersey, USA; Department of Oncology, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, Scottsdale, Arizona, USA · Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Oncology, University of Washington, Seattle, Washington, USA; Department of Oncology/Hematology, Sarah Cannon Research Institute, Nashville, Tennessee, USA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA; Department of Oncology, Peninsula Oncology Centre, Monash University, Frankston, Victoria, Australia; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA; Division of Clinical Oncology, Medizinische Universität Wien, Vienna, Austria; Mayo Clinic, Scottsdale, Arizona, USA; Department of Oncology, Prince of Wales Hospital, Randwick, New South Wales, Sydney, Australia; Celgene Corporation, Summit, New Jersey, USA; Department of Oncology, Virginia G. Piper Cancer Center at Scottsdale Healthcare/TGen, Scottsdale, Arizona, USA. · Pubmed 25582141
32 Other Locations Show
Yearly article counts 032634602200
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.